Endocrine Testing Market Share, Opportunities, Industry 2030

Segments - Endocrine Testing Market by Test Types (Estradiol Test, Follicle Stimulating Hormone Test, Human Chorionic Gonadotropin Hormone Test, Luteinizing Hormone Test, Dehydroepiandrosterone Sulfate Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone Test, Prolactin Test, Cortisol Test, Insulin Test, and Others), Technology (Tandem Mass Spectrometry, Immunoassay Technology, Monoclonal & Polyclonal Antibody Technology, Sensor Technology, Clinical Chemistry Technology, and Others), End-users (Hospital, Commercial Laboratory, Ambulatory Care Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, And Forecast 2021 – 2028

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global endocrine testing market size is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the rising endocrine disorders such as adrenal insufficiency and hyperthyroidism.

Endocrine systems consist of several glands that produce secrete hormones circulating in the human body. These hormones regulate several body functions such as growth and development, homeostasis, metabolism, stimulus response, and reproduction. Pituitary gland, pancreas, thyroid, hypothalamus, and adrenal glands are parts of the endocrine system. Secretion of hormones in these glands are used for various biochemical processes in the human body.

The endocrine test is primarily conducted to determine the concentrations of endocrine hormones in the human body such as insulin, estradiol, cortisol DHEA-S, testosterone, luteinizing, follicle stimulating hormone, human chorionic gonadotropin, and progesterone. The symptoms of an endocrine disorder vary and depends on particular gland while some common symptoms can be feeling lethargic, weak, or fatigued.

Technological advancements such as launch of easy-to-operate test kits have enabled the penetration of home-based diagnosis, which are cost effective and user friendly. Furthermore, aging population is the target of the market because of rising susceptibility to chronic diseases and huge risk of complications at the elder age that requires continuous health monitoring.

Market Trends, Drivers, Restraints, and Opportunities

Growing prevalence of endocrine disorders and chronic illness such as diabetes and obesity are major factors responsible for fueling the market growth during the forecast period.
Increasing consciousness about health and growing awareness of benefits regarding endocrine diagnostics among people are anticipated to drive the market expansion.
Rising geriatric population and favorable government initiatives encouraging the development of new diagnostics kits are projected to boost the growth of the market in the coming years.
High cost for the technology development and lack of skilled professionals to carry out endocrine testing procedure are key challenges that can restrain the market growth.
Ongoing R&D activities and technological advancement to improve diagnostic techniques and methods for better and effective treatment are offering major opportunities for the market expansion.

Scope of the Report

The report on the global endocrine testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Endocrine Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Test Types (Estradiol Test, Follicle Stimulating Hormone Test, Human Chorionic Gonadotropin Hormone Test, Luteinizing Hormone Test, Dehydroepiandrosterone Sulfate Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone Test, Prolactin Test, Cortisol Test, Insulin Test, and Others), Technology (Tandem Mass Spectrometry, Immunoassay Technology, Monoclonal & Polyclonal Antibody Technology, Sensor Technology, Clinical Chemistry Technology, and Others), and End-users (Hospital, Commercial Laboratory, Ambulatory Care Centers, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche, LabCorp, and Quest Diagnostics

Market Segment Insights

Thyroid stimulating hormone test segment to account for a key share
Based on test types, the global endocrine testing market is divided into estradiol test (E2), follicle stimulating hormone test (FSH), human chorionic gonadotropin hormone test (hCG), luteinizing hormone test (LH), dehydroepiandrosterone sulfate test (DHEAS), progesterone test, testosterone test, thyroid stimulating hormone test (TSH), prolactin test, cortisol test, insulin test, and others. The TSH test segment held a large market share in 2020 and is expected to account for a key revenue share in the coming years owing to rising disorders related to TSH and increasing awareness for relation between different levels of thyroid hormones cardiovascular disorders. However, the insulin test segment is expected to register a rapid growth rate during the forecast period. Growing number of the diabetic population and increasing awareness of several diagnosis are projected to increase demand for insulin tests. This is projected to boost the segment during the forecast period.

Global Endocrine Testing Market By Test Type

Sensor segment is expected to grow at a rapid pace
In terms of technology, the market is segmented into tandem mass spectrometry, immunoassay technology, monoclonal & polyclonal antibody technology, sensor technology, clinical chemistry technology and others. The tandem mass spectrometry is projected to expand at a substantial CAGR during the forecast period. The segment growth is attributed to increasing use of liquid chromatography combining with tandem mass spectrometry that aid to overcome challenges related to traditional techniques used in the testing. On the other hand, the sensor segment is projected to grow at a rapid pace as compared to all other segments because of increasing use of biosensors for diabetes in glucose monitoring, which is primarily used by patients to check their blood sugar level on a daily basis.

Global Endocrine Testing Market By Technology

Hospital segment to hold a large market share
On the basis of end-users, the global endocrine testing market is divided into hospital, commercial laboratory, ambulatory care centers, and others. The hospital segment is anticipated to hold a large market share during the forecast period owing to wide availability of skilled professionals and advanced infrastructure in hospitals. Moreover, high adoption of innovative testing devices in hospitals as compared to others such as clinics act as a key driver for the segment growth.

Asia Pacific region to register a high CAGR
Based on regions, the global endocrine testing market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period owing to well-establishment of the primary, secondary, and tertiary care hospitals along with increasing awareness about use of advanced technologies among people.

The market of Asia-Pacific, however, is expected to exhibit a rapid growth rate in the coming years owing to key factors such as increasing expenditure on R&D by private agencies and government for improving diagnosis in the region. Constructive government initiatives for reimbursement policies and healthcare infrastructure in emerging economies such as China, India, and Japan are projected to drive the regional market growth.

Global Endocrine Testing Market By Region

Segments

Segments Covered in the Report
The global endocrine testing market has been segmented on the basis of

Test Types

Estradiol Test
Follicle Stimulating Hormone Test
Human Chorionic Gonadotropin Hormone Test
Luteinizing Hormone Test
Dehydroepiandrosterone Sulfate Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone Test
Prolactin Test
Cortisol Test
Insulin Test
Others

Technology

Tandem Mass Spectrometry
Immunoassay Technology
Monoclonal & Polyclonal Antibody Technology
Sensor Technology
Clinical Chemistry Technology
Others

End-users

Hospital
Commercial Laboratory
Ambulatory Care Centers
Others

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Abbott Laboratories
AB Sciex
Agilent Technologies
Biomedical Technologies
bioMerieux SA
Bio Rad Laboratories
DiaSorin
Hoffmann-La Roche
LabCorp
Quest Diagnostics

Competitive Landscape

Some of the key players competing in the global endocrine testing market include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.

Many players are concentrating on strategic initiatives such as mergers and acquisitions, co-development deals, product launches and development, and licensing partnerships to increase their products portfolio. Moreover, these competitors are focusing on strategies such as introducing technological advanced products and collaboration to sustain in the competition.

Global Endocrine Testing Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Endocrine Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Endocrine Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Endocrine Testing Market - Supply Chain
  4.5. Global Endocrine Testing Market Forecast
     4.5.1. Endocrine Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Endocrine Testing Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Endocrine Testing Market Absolute $ Opportunity
5. Global Endocrine Testing Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Endocrine Testing Market Size and Volume Forecast by Types
     5.3.1. Estradiol Test
     5.3.2. Follicle Stimulating Hormone Test
     5.3.3. Human Chorionic Gonadotropin Hormone Test
     5.3.4. Luteinizing Hormone Test
     5.3.5. Dehydroepiandrosterone Sulfate Test
     5.3.6. Progesterone Test
     5.3.7. Testosterone Test
     5.3.8.
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Endocrine Testing Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Endocrine Testing Market Size and Volume Forecast by End Users
     6.3.1. Hospital
     6.3.2. Commercial Laboratory
     6.3.3. Ambulatory Care Centers
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Endocrine Testing Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Endocrine Testing Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Endocrine Testing Demand Share Forecast, 2019-2026
8. North America Endocrine Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Endocrine Testing Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Endocrine Testing Market Size and Volume Forecast by Types
     8.4.1. Estradiol Test
     8.4.2. Follicle Stimulating Hormone Test
     8.4.3. Human Chorionic Gonadotropin Hormone Test
     8.4.4. Luteinizing Hormone Test
     8.4.5. Dehydroepiandrosterone Sulfate Test
     8.4.6. Progesterone Test
     8.4.7. Testosterone Test
     8.4.8.
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Endocrine Testing Market Size and Volume Forecast by End Users
     8.7.1. Hospital
     8.7.2. Commercial Laboratory
     8.7.3. Ambulatory Care Centers
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Endocrine Testing Demand Share Forecast, 2019-2026
9. Latin America Endocrine Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Endocrine Testing Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Endocrine Testing Market Size and Volume Forecast by Types
     9.4.1. Estradiol Test
     9.4.2. Follicle Stimulating Hormone Test
     9.4.3. Human Chorionic Gonadotropin Hormone Test
     9.4.4. Luteinizing Hormone Test
     9.4.5. Dehydroepiandrosterone Sulfate Test
     9.4.6. Progesterone Test
     9.4.7. Testosterone Test
     9.4.8.
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Endocrine Testing Market Size and Volume Forecast by End Users
     9.7.1. Hospital
     9.7.2. Commercial Laboratory
     9.7.3. Ambulatory Care Centers
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Endocrine Testing Demand Share Forecast, 2019-2026
10. Europe Endocrine Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Endocrine Testing Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Endocrine Testing Market Size and Volume Forecast by Types
     10.4.1. Estradiol Test
     10.4.2. Follicle Stimulating Hormone Test
     10.4.3. Human Chorionic Gonadotropin Hormone Test
     10.4.4. Luteinizing Hormone Test
     10.4.5. Dehydroepiandrosterone Sulfate Test
     10.4.6. Progesterone Test
     10.4.7. Testosterone Test
     10.4.8.
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Endocrine Testing Market Size and Volume Forecast by End Users
     10.7.1. Hospital
     10.7.2. Commercial Laboratory
     10.7.3. Ambulatory Care Centers
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Endocrine Testing Demand Share Forecast, 2019-2026
11. Asia Pacific Endocrine Testing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Endocrine Testing Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Endocrine Testing Market Size and Volume Forecast by Types
     11.4.1. Estradiol Test
     11.4.2. Follicle Stimulating Hormone Test
     11.4.3. Human Chorionic Gonadotropin Hormone Test
     11.4.4. Luteinizing Hormone Test
     11.4.5. Dehydroepiandrosterone Sulfate Test
     11.4.6. Progesterone Test
     11.4.7. Testosterone Test
     11.4.8.
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Endocrine Testing Market Size and Volume Forecast by End Users
     11.7.1. Hospital
     11.7.2. Commercial Laboratory
     11.7.3. Ambulatory Care Centers
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Endocrine Testing Demand Share Forecast, 2019-2026
12. Middle East & Africa Endocrine Testing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by Types
     12.4.1. Estradiol Test
     12.4.2. Follicle Stimulating Hormone Test
     12.4.3. Human Chorionic Gonadotropin Hormone Test
     12.4.4. Luteinizing Hormone Test
     12.4.5. Dehydroepiandrosterone Sulfate Test
     12.4.6. Progesterone Test
     12.4.7. Testosterone Test
     12.4.8.
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Endocrine Testing Market Size and Volume Forecast by End Users
     12.7.1. Hospital
     12.7.2. Commercial Laboratory
     12.7.3. Ambulatory Care Centers
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Endocrine Testing Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Endocrine Testing Market: Market Share Analysis
  13.2. Endocrine Testing Distributors and Customers
  13.3. Endocrine Testing Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Abbott Laboratories
     13.4.2. AB Sciex
     13.4.3. Agilent Technologies
     13.4.4. Biomedical Technologies
     13.4.5. bioMerieux SA
     13.4.6. Bio Rad Laboratories
     13.4.7. DiaSorin
     13.4.8. Hoffmann-La Roche
     13.4.9.